Introduction
ANXA2, a member of the annexin family, plays a crucial role in regulating cellular growth and signal transduction pathways. This protein acts as an autocrine factor that stimulates osteoclast formation and bone resorption, making it significant in conditions like sickle cell osteonecrosis. Reduced ANXA2 expression is linked to osteosarcoma metastases. Functioning as part of the cell surface vitamin D binding protein binding site complex, ANXA2 mediates the chemotactic cofactor effect. Its involvement extends to dysferlin deficiency and muscular dystrophies. Notably, an up-regulation of ANXA2 is observed during human colon adenocarcinoma cell differentiation.
Description
Recombinant human ANXA2, produced in E. coli, is a single, non-glycosylated polypeptide chain comprising 376 amino acids (1-339a.a.). With a molecular mass of 42.8 kDa, this protein is fused to a 37 amino acid His-Tag at its N-terminus and undergoes purification using proprietary chromatographic techniques.
Physical Appearance
Clear, colorless solution that has been sterilized by filtration.
Formulation
The ANXA2 solution (0.5mg/ml) is supplied in a buffer containing 20mM Tris-HCl (pH 8), 0.1M NaCl, and 20% glycerol.
Stability
For short-term storage (2-4 weeks), the solution should be kept at 4°C. For extended storage, it is recommended to freeze the solution at -20°C. The addition of a carrier protein (0.1% HSA or BSA) is advised for long-term storage. It is crucial to avoid repeated freeze-thaw cycles.
Purity
The purity of ANXA2 is determined to be greater than 95% by SDS-PAGE analysis.
Synonyms
ANX2, ANX2L4, CAL1H, LIP2, LPC2, LPC2D, P36, PAP-IV, ANXA2, Annexin A2, Annexin-2, Annexin II, Lipocortin II, Calpactin-1 heavy chain, Calpactin I heavy chain, Chromobindin-8, p36, Protein I, Placental anticoagulant protein IV.
Amino Acid Sequence
MRGSHHHHHH GMASMTGGQQ MGRDLYDDDD KDRWGSHMST VHEILCKLSL EGDHSTPPSA YGSVKAYTNF DAERDALNIE TAIKTKGVDE VTIVNILTNR SNAQRQDIAF AYQRRTKKEL ASALKSALSG HLETVILGLL KTPAQYDASE LKASMKGLGT DEDSLIEIIC SRTNQELQEI NRVYKEMYKT DLEKDIISDT SGDFRKLMVA LAKGRRAEDG SVIDYELIDQ DARDLYDAGV KRKGTDVPKW ISIMTERSVP HLQKVFDRYK SYSPYDMLES IRKEVKGDLE NAFLNLVQCI QNKPLYFADR LYDSMKGKGT RDKVLIRIMV SRSEVDMLKI RSEFKRKYGK SLYYYIQQDT KGDYQKALLY LCGGDD.